IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors

Int J Biol Sci. 2023 Aug 6;19(13):4181-4203. doi: 10.7150/ijbs.85158. eCollection 2023.

Abstract

The effective approach to discover innovative drugs will ask natural products for answers because of their complex and changeable structures and multiple biological activities. Inhibitory kappa B kinase beta (IKKβ), known as IKK2, is a key regulatory kinase responsible for the activation of NF-κB through its phosphorylation at Ser177 and Ser181 to promote the phosphorylation of inhibitors of kappa B (IκBs), triggering their ubiquitination and degradation to active the nuclear factor kappa-B (NF-κB) cascade. Chemical inhibition of IKKβ or its genetic knockout has become an effective method to block NF-κB-mediated proliferation and migration of tumor cells and inflammatory response. In this review, we summarized the structural feature and transduction mechanism of IKKβ and the discovery of inhibitors from natural resources (e.g. sesquiterpenoids, diterpenoids, triterpenoids, flavonoids, and alkaloids) and chemical synthesis (e.g. pyrimidines, pyridines, pyrazines, quinoxalines, thiophenes, and thiazolidines). In addition, the biosynthetic pathway of novel natural IKKβ inhibitors and their biological potentials were discussed. This review will provide inspiration for the structural modification of IKKβ inhibitors based on the skeleton of natural products or chemical synthesis and further phytochemistry investigations.

Keywords: Bioactivity; IKKβ; Inhibitor; Natural products; chemical synthesis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products* / pharmacology
  • I-kappa B Kinase* / genetics
  • NF-kappa B
  • Phosphorylation
  • Protein Serine-Threonine Kinases

Substances

  • I-kappa B Kinase
  • NF-kappa B
  • Protein Serine-Threonine Kinases
  • Biological Products